Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results more »

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform more »

OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017 more »

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy more »

Email Alert Registration

Please fill out the form below to sign up for event notifications. Providing this information will allow you to gain full access to our online Investor Relations services. * Required fields

 
 
 
 
 
 


 
This helps OPKO Health, Inc. prevent automated submissions.

Email  Sign up for email alerts